Adverum Biotechnologies (ADVM) Misses Q3 EPS by 130c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($1.30). Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• EagleOne Metals closes $225,199 non-brokered private placement
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue